Biolife solutions closes acquisition of sexton biotechnologies

Bothell, wash., sept. 1, 2021 /prnewswire/ -- biolife solutions, inc. (nasdaq: blfs) ("biolife" or the "company"), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced that it has closed its acquisition of sexton biotechnologies.

BLFS Ratings Summary

BLFS Quant Ranking